Location: Atlanta, Georgia
Discover Your Career at Emory University
Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the diversity and excellence of our academic community.
The Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and the Emory University Department of Pediatrics invites interested applicants for a faculty level position in pediatric Blood and Marrow Transplantation. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical, and translational research and boasts a diverse faculty. The Blood and Marrow Transplant (BMT) Program is one of the largest pediatric BMT programs in the country, performing more than 70 lifesaving BMTs in 2021, one of the largest volumes in the country. The BMT program is an integral component of the Aflac Cancer & Blood Disorders Center, and currently includes 12 faculty members, with a broad range of basic, clinical and translational research.
Qualified candidates should be Board Certified/Eligible Hematologist/Oncologists, and preference will be given to applicants who wish to continue a career focused on transplantation and cellular therapy for hematologic malignancies. This is a clinical position, and research commitment is flexible depending on the candidate's qualifications. Rank of assistant or associate professor will depend on experience and accomplishments.
About the Aflac Cancer & Blood Disorders CenterThe successful candidate will join one of the strongest pediatric hematology/oncology programs in the country.
* In 2022, the Aflac Cancer & Blood Disorders Center was ranked No. 7 in the nation for Pediatric Cancer by US News and World Report* Each year our team cares for more than 150 newly diagnosed leukemia and lymphoma patients using a variety of treatment protocols, including blood and marrow transplant (BMT), hematopoietic stem cell transplant, chimeric antigen receptor (CAR)-T therapy, and Phase I and II clinical trials for patients whose cancer has relapsed or is not responding to treatment* The Aflac Cancer & Blood Disorders Center has 115 faculty and 35 Advance Practice Providers (APPs), conducting basic, translational, cooperative group and investigator-initiated clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, cancer survivorship, health services research, hemoglobinopathies and hemophilia.* More than 7,000 children with cancer and blood disorders are treated annually at the Aflac Cancer & Blood Disorders Center* The Aflac pediatric oncology program sees ~500 new cancer diagnoses each year. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.* The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease, and 600 with bleeding or clotting disorders)* The Aflac blood and marrow transplantation program performs ~80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.* In 2021, Aflac faculty generated $34.5M in extramural funding, including more than $21.9M from the NIH* The Aflac fellowship program accepts 6 fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH-funded T32 training grant in non-malignant hematology* The Aflac Developmental Therapeutics Program includes Leukemia and Lymphoma faculty from the high-risk leukemia team and offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator-initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN), NANT, TACL, and PBTC.* The MIBG and Relapsed Neuroblastoma Program is the largest in the southeast and has treated ~100 patients with therapeutic MIBG since its inception in 2013.
This position offers a wealth of opportunities for research collaborations within the Department of Pediatrics, Winship Cancer Institute, Grady Hospital as well as with Emory basic science departments, the Rollins School of Public Health, the Georgia Institute of Technology, Morehouse School of Medicine and the Centers for Disease Control and Prevention.
Successful candidates will have:* MD, MD/PhD, or DO degrees* Must be Board Certified in Pediatric Hematology-Oncology* Must be currently licensed as a physician and eligible for licensure as a physician in the State of Georgia* A history of clinical excellence/achievement
The Emory + Children's Pediatric Institute is an affiliation between Emory University and Children's Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care, conducting innovative basic science discovery and clinical research, and coordinating exceptional education of the future healthcare workforce. Our physicians, researchers, and educators have created a model where leadership, commitment and quality are fundamental components of success. Together, we are transforming pediatrics by achieving new levels of clinical excellence--driven by research, teaching and wellness. We look forward to our future together.
Emory Supports a Diverse and Inclusive Culture
To ensure the safety of our campus community, the COVID-19 vaccine is required. For more information on the University and Hospital policies and potential exemptions, please see our website. Emory University is dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, gender, genetic information, age, disability, sexual orientation, gender identity, gender expression, and veteran's status. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University programs and in the use of facilities without such discrimination. Emory University complies with Executive Order 11246, as amended, Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran's Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity and affirmative action. Emory University is committed to achieving a diverse workforce through application of its affirmative action, equal opportunity and nondiscrimination policy in all aspects of employment including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Inquiries regarding this policy should be directed to the Emory University Department of Equity and Inclusion, 201 Dowman Drive, Administration Building, Atlanta, GA 30322. Emory University is committed to providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to request a reasonable accommodation, please contact the Department of Accessibility Services at 404-727-9877 (V) | 404-712-2049 (TDD). Please note that one week advance notice is preferred.